Sort by
Letter to Shareholders - Annual General Meeting
Notice of Annual General Meeting/Proxy Form
Appendix 4C - Quarterly - 30 September 2026
RLS-2202 Phase 1a Trial Advances to Cohort 2
Investor Presentation
Investor Webinar
Date of AGM and Closing Date for Director Nominations
Notification of cessation of securities - PAB
Patrys Completes Cohort 1 Dosing and Follow-Up
Appendix 4E Variance Report
| Date | Headline |
|---|---|
30 Oct 2026 | Letter to Shareholders - Annual General Meeting |
30 Oct 2026 | Notice of Annual General Meeting/Proxy Form |
29 Oct 2026 | Appendix 4C - Quarterly - 30 September 2026 |
22 Oct 2026 | RLS-2202 Phase 1a Trial Advances to Cohort 2 |
13 Oct 2026 | Investor Presentation |
6 Oct 2026 | Investor Webinar |
5 Oct 2026 | Date of AGM and Closing Date for Director Nominations |
30 Sep 2026 | Notification of cessation of securities - PAB |
29 Sep 2026 | Patrys Completes Cohort 1 Dosing and Follow-Up |
28 Sep 2026 | Appendix 4E Variance Report |
